Geopolitics of Technology

Business

Regeneron Aims to Redefine Obesity Treatment with Dual-Action Drug Targeting Weight and Cholesterol

Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.

Jan 30, 2026

Business

Market Mismatch: Three Undervalued Stocks Trading at Steep Discounts

Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.

Jan 30, 2026

Business

Covenant Logistics Eyes 2026 Turnaround, Citing Early Rate Gains and Strategic Fleet Reshaping

Despite posting a Q4 net loss, Covenant Logistics signals a shift in market dynamics, with executives pointing to rising spot rates, secured contract increases, and a disciplined fleet strategy as precursors to a stronger performance by late 2026.

Jan 30, 2026

Business

Beyond the Blue Chips: Three Small-Cap Stocks Gaining Investor Attention

While major indices hold steady, a search for growth is turning the spotlight onto smaller companies. We examine three small-cap stocks—from insurance to banking to luxury watches—that are posting strong results and navigating unique challenges in the current market.

Jan 30, 2026

Business

Trump Administration Shifts Course, Scraps Price Guarantees for Critical Minerals Projects

The White House has backed away from plans to set minimum prices for domestic critical minerals projects, telling industry leaders that ventures must stand on their own financially. The policy reversal, driven by funding uncertainties and market concerns, marks a significant shift in strategy for bolstering the U.S. supply chain.

Jan 30, 2026

Business

SkyWest Secures Long-Term Deals with Major Carriers, Anchoring E175 Fleet Expansion Through 2028

Regional airline SkyWest, Inc. has locked in multi-year contract extensions with United Airlines and Delta Air Lines for its Embraer E175 aircraft, providing a stable foundation for growth and improved financial visibility. The agreements solidify the company's fleet strategy and partnership with Embraer amid a competitive landscape.

Jan 30, 2026

Business

Carnival Stock Surges 9.3% on Record Earnings, Dividend Return, and NYSE Unification Plan

Carnival Corporation & plc sees its shares rally after posting a record $4.5 billion in operating income for fiscal 2025, reinstating a quarterly dividend, and announcing plans to consolidate its dual-listed structure into a single NYSE entity, signaling a renewed focus on shareholder returns and corporate simplicity.

Jan 30, 2026

Business

Amneal Pharmaceuticals: A Deep Value Play After Stellar Run?

Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.

Jan 30, 2026

Business

Paramount Skydance Bets on Live Sports Ads and Dividends to Steady Its Course

Paramount Skydance is launching a new programmatic advertising platform for live sports on Paramount+ and initiating a quarterly dividend, signaling a strategic shift towards monetizing its existing audience amid ongoing financial pressures.

Jan 30, 2026

Business

SSR Mining Shares Retreat from 15-Year High as Gold Prices Cool

Despite a sharp pullback following gold's price dip, analysts remain bullish on SSR Mining, citing strong earnings potential and attractive valuation metrics even after its stellar run.

Jan 30, 2026

Business

Scout Motors' South Carolina EV Plant Hits $150M Overrun, Taxpayers Asked to Cover Costs

Three years after securing $1.3 billion in state incentives, Volkswagen-backed Scout Motors' planned electric vehicle factory faces mounting public costs amid wetland mitigation and inflation, raising questions about risk allocation.

Jan 30, 2026

Business

KLA Shares Tumble 11.5% as Supply Chain and Tariff Concerns Overshadow Strong Earnings

Despite posting quarterly results that beat analyst expectations, KLA Corporation's stock plunged Friday as investors focused on management warnings about component shortages, tariff impacts, and operational constraints.

Jan 30, 2026

Business

U.S. Wholesale Inflation Surges in December, Fueled by Jump in Service Costs

U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.

Jan 30, 2026

Business

Robinhood's Kalshi Parlay Launch Sparks Record-Breaking Surge, Outpacing Non-Sports Markets

Kalshi's parlay betting, newly accessible via Robinhood, generated unprecedented single-day fee revenue last Sunday, surpassing the platform's historical earnings from all non-sports events combined and signaling a major shift in the prediction market landscape.

Jan 30, 2026

Business

Silphium Asset Management Exits $6.2 Million Vanguard Bond ETF Stake, Signaling Shift in Fixed-Income Strategy

London-based Silphium Asset Management has liquidated its entire $6.2 million position in the Vanguard Long-Term Corporate Bond ETF (VCLT), a move that raises questions about institutional appetite for long-duration credit amid shifting economic forecasts.

Jan 30, 2026

Business

Elevation Capital Makes Strategic $9.8 Million Move Into 'Fallen Angel' Bond ETF

Investment firm Elevation Capital has significantly increased its stake in the VanEck Fallen Angel High Yield Bond ETF (ANGL), a fund targeting corporate bonds downgraded from investment grade, signaling a strategic bet on higher yields in a shifting credit environment.

Jan 30, 2026

Business

Climate Crisis Puts Global Seafood Industry on the Brink: Adaptation Demands Urgent Investment

A stark new financial analysis warns that ocean warming and extreme weather could cost the seafood sector $15 billion annually by 2050, threatening food security and economies worldwide.

Jan 30, 2026

Business

Regeneron Caps 2025 with Strong Quarter, Eyes Pipeline Expansion Amid EYLEA Transition

Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.

Jan 30, 2026

Business

Sanfilippo Navigates Price-Volume Squeeze, Delivers Strong Q2 Earnings on Cost Discipline

John B. Sanfilippo & Son posts record revenue and a 32% jump in EPS for fiscal Q2 2026, even as higher nut costs and shifting consumer habits pressure sales volumes. The snack nut processor eyes future growth through operational efficiency and new bar production capacity.

Jan 30, 2026

Business

Beyond the Hype: Five Stocks Poised to Define the 2026 Investment Landscape

As 2026 unfolds, the AI investment thesis is maturing beyond initial skepticism, creating opportunities in both leading tech giants and overlooked sectors. We analyze five companies, from semiconductor powerhouses to regional e-commerce leaders, positioned for a pivotal year.

Jan 30, 2026